Portuguese study reveals Real-World use of breast cancer drugs
NCT ID NCT07223476
First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 25 times
Summary
This study examined how CDK4/6 inhibitors, a type of targeted therapy, are actually used in hospitals across Portugal for advanced or metastatic breast cancer. Researchers looked at data from 16 public hospitals involving nearly 2,000 patients to understand treatment patterns, how long patients stayed on therapy, and how often doses were adjusted. The goal was to gather real-world evidence to complement clinical trial findings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis
East Hanover, New Jersey, 07936, United States
Conditions
Explore the condition pages connected to this study.